Mannatech Announces Results of Annual Shareholders’ Meeting
Mannatech’s Chairman of the Board, J. Stanley Fredrick, chaired the Meeting and David Johnson, Mannatech’s Chief Financial Officer, spoke to the shareholders sharing the company’s financial results for 2022 and the first quarter of 2023.
There were 1,872,422 outstanding shares of Mannatech’s common stock as of April 20, 2023 entitled to vote and 1,270,511 shares, or approximately
The following matters were submitted and voted upon at the Meeting:
1. Mannatech shareholders voted on the election of one individual to the Board of Directors as Class III Directors to hold office until 2026 as set forth below:
Name |
Number of Shares For |
Number of Shares Withheld |
Broker Non-Votes |
John A. Seifrick |
727,445 |
212,976 |
330,090 |
2. Mannatech shareholders voted to ratify the appointment of BDO
Number of Shares For |
Number of Shares Against |
Number of Shares Abstaining |
1,251,033 |
16,410 |
3,068 |
3. Mannatech shareholders approved, on an advisory basis, the compensation of Mannatech’s named executive officers as set forth below:
Number of Shares For |
Number of Shares Against |
Number of Shares Abstaining |
Broker Non-Votes |
922,392 |
16,676 |
1,353 |
330,090 |
To begin improving your life and the lives of those around you, please visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, is committed to transforming lives through the development, marketing, and sales of high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products distributed through its global network of independent associates and members. The company has been operating for more than 25 years of experience with operations in 25 markets^. For more information, visit Mannatech.com.
^Mannatech operates in
Please Note: This release contains “forward-looking statements.” These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the SEC and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's ability to complete the anticipated tender offer in a timely manner or at all, the price at which shares of the Company's common stock may trade on Nasdaq, which may be higher or lower than the purchase price in the anticipated tender offer, uncertainty as to the number of shares purchased in the tender offer, the impact of the outbreak of the novel coronavirus ("COVID-19") pandemic, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the SEC, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005784/en/
Donna Giordano
972-471-6512
ir@mannatech.com
Source: Mannatech, Incorporated
